A Phase III Randomized, Multicenter, Multinational, Double-Masked, Placebo-Controlled Study of Photrex (Rostaporfin) Photodynamic Therapy in the Treatment of Classic and Occult Subfoveal Choroidal Neovascularization Associated With AMD
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Rostaporfin (Primary)
- Indications Age-related macular degeneration
- Focus Therapeutic Use
- Sponsors Miravant Pharmaceuticals
- 31 Jan 2017 New trial record